These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 2647896

  • 1. Principles of cancer pain management. Use of long-acting oral morphine.
    Brooks I, De Jager R, Blumenreich M, George E, Savarese JJ.
    J Fam Pract; 1989 Mar; 28(3):275-80. PubMed ID: 2647896
    [Abstract] [Full Text] [Related]

  • 2. Control of severe pain with sustained-release morphine tablets v. oral morphine solution.
    Arkinstall WW, Goughnour BR, White JA, Stewart JH.
    CMAJ; 1989 Mar 15; 140(6):653-7, 661. PubMed ID: 2645988
    [Abstract] [Full Text] [Related]

  • 3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Mar 15; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 4. Guidelines for use of controlled-release oral morphine in cancer pain management. Correlation with clinical experience.
    Lapin J, Portenoy RK, Coyle N, Houde RW, Foley KM.
    Cancer Nurs; 1989 Aug 15; 12(4):202-8. PubMed ID: 2766263
    [Abstract] [Full Text] [Related]

  • 5. [Long-term therapy of tumor pain using morphine-retard tablets].
    Sorge J, Lehmkuhl C, Lohse K, Herrmann H, Pichlmayr I.
    Med Klin (Munich); 1990 Sep 15; 85(9):523-8. PubMed ID: 2233610
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design.
    Cundiff D, McCarthy K, Savarese JJ, Kaiko R, Thomas G, Grandy R, Goldenheim P.
    Cancer; 1989 Jun 01; 63(11 Suppl):2355-9. PubMed ID: 2720581
    [Abstract] [Full Text] [Related]

  • 7. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, Villari P, Ficorella C, Gebbia V, Riina S, Casuccio A, Mangione S.
    Eur J Pain; 2008 Nov 01; 12(8):1040-6. PubMed ID: 18353696
    [Abstract] [Full Text] [Related]

  • 8. Effervescent morphine results in faster relief of breakthrough pain in patients compared to immediate release morphine sulfate tablet.
    Freye E, Levy JV, Braun D.
    Pain Pract; 2007 Dec 01; 7(4):324-31. PubMed ID: 17986159
    [Abstract] [Full Text] [Related]

  • 9. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM, Shi M, Buckley BJ, Kwarcinski MA.
    Clin Ther; 2006 Jan 01; 28(1):86-98. PubMed ID: 16490582
    [Abstract] [Full Text] [Related]

  • 10. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R, Smit JM, Schipper RM, Wicks MA, Zuurmond WW.
    Curr Med Res Opin; 2003 Jan 01; 19(6):457-69. PubMed ID: 14594516
    [Abstract] [Full Text] [Related]

  • 11. The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during 'titration phase' in patients with cancer pain.
    De Conno F, Ripamonti C, Fagnoni E, Brunelli C, Luzzani M, Maltoni M, Arcuri E, Bertetto O, MERITO Study Group.
    Palliat Med; 2008 Apr 01; 22(3):214-21. PubMed ID: 18477715
    [Abstract] [Full Text] [Related]

  • 12. Pain management of opioid-treated cancer patients in hospital settings in Denmark.
    Lundorff L, Peuckmann V, Sjøgren P.
    Acta Anaesthesiol Scand; 2008 Jan 01; 52(1):137-42. PubMed ID: 18005379
    [Abstract] [Full Text] [Related]

  • 13. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose.
    Mercadante S, Villari P, Ferrera P, Bianchi M, Casuccio A.
    J Pain Symptom Manage; 2004 Apr 01; 27(4):352-9. PubMed ID: 15050663
    [Abstract] [Full Text] [Related]

  • 14. [Morphine tablets for chronic non-tumor-induced pain. Which factors modify the success or failure of a long-term therapy?].
    Schulzeck S, Gleim M, Maier C.
    Anaesthesist; 1993 Aug 01; 42(8):545-56. PubMed ID: 8368476
    [Abstract] [Full Text] [Related]

  • 15. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
    Yu SY, Qiu H, Ma ZS, Chen J, Zhang Y, Chen LZ, Wang DL, Ma ZY.
    Zhonghua Yi Xue Za Zhi; 2004 Mar 17; 84(6):450-5. PubMed ID: 15061959
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ, Ahmedzai SH, Allan LG, Camacho F, Horbay GL, Richarz U, Simpson K.
    Curr Med Res Opin; 2004 Sep 17; 20(9):1419-28. PubMed ID: 15383190
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer].
    Oztürk T, Karadibak K, Catal D, Cakan A, Tugsavul F, Cirak K.
    Agri; 2008 Jul 17; 20(3):20-5. PubMed ID: 19085178
    [Abstract] [Full Text] [Related]

  • 18. Management of cancer pain with oral controlled-release morphine sulfate.
    Meed SD, Kleinman PM, Kantor TG, Blum RH, Savarese JJ.
    J Clin Pharmacol; 1987 Feb 17; 27(2):155-61. PubMed ID: 3680567
    [Abstract] [Full Text] [Related]

  • 19. Controlled-release oral morphine sulfate in the treatment of cancer pain with pharmacokinetic correlation.
    Khojasteh A, Evans W, Reynolds RD, Thomas G, Savarese JJ.
    J Clin Oncol; 1987 Jun 17; 5(6):956-61. PubMed ID: 3585450
    [Abstract] [Full Text] [Related]

  • 20. Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain.
    Hagen NA, Thirlwell M, Eisenhoffer J, Quigley P, Harsanyi Z, Darke A.
    J Pain Symptom Manage; 2005 Jan 17; 29(1):80-90. PubMed ID: 15652441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.